[1]
2013. Myxovirus resistance, osteopontin and suppressor of cytokine signaling 3 polymorphisms predict hepatitis C virus therapy response in an admixed patient population: comparison with IL28B. Clinics. 68, 10 (Oct. 2013), 1325–1332. DOI:https://doi.org/10.1590/clin.v68i10.77009.